Renal Insufficiency, Chronic: all 3,224 studies
Page 32 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.
- Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney DiseaseCompletedNCT00506506Phase 3
- A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT00505037Phase 2
- The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney DiseaseCompletedNCT00498342Not applicable
- A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.TerminatedNCT00495365Phase 4
- Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis PatientsCompletedNCT00485706Not applicable
- Fall Prevention by Alfacalcidol and TrainingWithdrawnNCT00483275Phase 4
- Follow-up Study to Previous CARE TrialCompletedNCT00479024
- Loop Diuretics in Chronic Kidney DiseaseCompletedNCT00478543Phase 4
- Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599Not applicable
- Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum CarbonateCompletedNCT00458289Phase 1
- Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney DiseaseCompletedNCT00456859Phase 4
- Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TerminatedNCT00452478Phase 4
- Rosiglitazone and Insulin Resistance in Renally Impaired PatientsTerminatedNCT00452166Phase 3
- A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With HyperphosphatemiaTerminatedNCT00451295Phase 3
- Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney DiseaseStatus unknownNCT00446615Not applicable
- A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.CompletedNCT00442793Phase 3
- Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial FunctionSuspendedNCT00442299Phase 1/2
- The Role of P-cresol and Related Protein Fermentation Metabolites in Chronic Kidney Disease PatientsCompletedNCT00441623
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCompletedNCT00440648Phase 2
- A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNCT00437723Phase 4
- Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving DialysisCompletedNCT00436995Phase 3
- The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis PatientsTerminatedNCT00433342Phase 1
- The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal DialysisCompletedNCT00433264
- Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis PatientsCompletedNCT00412139
- Ergocalciferol in Chronic Kidney DiseaseCompletedNCT00411294
- Evaluation of Colecalciferol Substitution in Dialysis PatientsCompletedNCT00397475Not applicable
- Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis PatientsCompletedNCT00397306Not applicable
- Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC StudyCompletedNCT00396123
- Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney DiseaseCompletedNCT00395382Phase 4
- Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease PatientsCompletedNCT00395005
- Assessing Novel Methods of Improving Patient Education of NutritionCompletedNCT00394576Not applicable
- Impact of Screening Patients With HIV for Kidney DiseaseWithdrawnNCT00392132
- Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)CompletedNCT00390585Phase 4
- Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney DiseaseWithdrawnNCT00384657Phase 3
- Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) StudyTerminatedNCT00384618Phase 4
- Prevalence of Chronic KIdney Disease in Hypertensive PatientsStatus unknownNCT00383968
- External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular AccessTerminatedNCT00379366Phase 2/3
- Klotho Gene Polymorphism in Dialyzed Patients With HyperphosphatemiaTerminatedNCT00374712
- STAAR-1 Clinical StudyCompletedNCT00369772Phase 4
- STAAR-3 Clinical StudyCompletedNCT00369733Phase 4
- STAAR-2 Clinical StudyCompletedNCT00368901Phase 4
- Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2
- MMF After Pediatric Liver TransplantationCompletedNCT00367146Not applicable
- Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney DiseaseStatus unknownNCT00364884Phase 4
- The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)CompletedNCT00358306
- Mechanisms of Erythropoietin Action in the Cardiorenal SyndromeCompletedNCT00356733Phase 3
- ADMA Levels in End-Stage Renal DiseaseCompletedNCT00350974
- Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or InterventionCompletedNCT00345501Phase 2/3
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal InsufficiencyTerminatedNCT00338091Not applicable
- EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal FailureCompletedNCT00338000Phase 4
- Dialysis Clinical Outcomes Revisited (DCOR) TrialCompletedNCT00324571Phase 4
- Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer DosingCompletedNCT00324376Phase 2
- Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA StudyStatus unknownNCT00323713Not applicable
- Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or HypertensionCompletedNCT00313430
- Effects of Early Correction of Anemia in Patients With Chronic Renal InsufficiencyTerminatedNCT00312871Phase 4
- Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)CompletedNCT00308971Phase 2
- Changes in Iron Markers Following Iron Loading in Hemodialysis PatientsCompletedNCT00308490Phase 4
- A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)CompletedNCT00307814Phase 2
- SDCC - Prospective Cohort Study of Chronic Renal InsufficiencyActive, not recruitingNCT00304148
- Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal DiseaseCompletedNCT00298129
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?CompletedNCT00291720Phase 2
- Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk PatientsCompletedNCT00285298Phase 3
- NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin LevelsStatus unknownNCT00279084Not applicable
- Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
- Benazepril for Advanced Chronic Renal InsufficiencyTerminatedNCT00270426Not applicable
- Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisCompletedNCT00268957Phase 3
- Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis PatientsCompletedNCT00267514Phase 3
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255437Phase 3
- Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255424Phase 3
- Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On DialysisCompletedNCT00242164Phase 2
- Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal AnemiaStatus unknownNCT00238043Phase 3
- Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney DiseaseStatus unknownNCT00235287Phase 4
- Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney DiseaseCompletedNCT00234702Phase 2
- The Canadian Prevention of Renal and Cardiovascular Endpoints TrialCompletedNCT00231803Not applicable
- Peginesatide for Anemia in Chronic Hemodialysis PatientsCompletedNCT00228449Phase 2
- Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease PatientsCompletedNCT00228436Phase 2
- MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent ApplicationCompletedNCT00223548Phase 2
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedNCT00221845Phase 3
- A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.CompletedNCT00212875Phase 2
- EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)CompletedNCT00211978Phase 3
- A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin AlfaCompletedNCT00211068
- Intravenous Iron in Patients With Anemia of Chronic Kidney DiseaseStatus unknownNCT00204256Phase 4
- Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal DialysisCompletedNCT00196755Phase 3
- Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney DiseaseTerminatedNCT00194961Phase 4
- Effect of Cytokines on Growth of Children With Chronic Kidney FailureSuspendedNCT00194883Phase 4
- Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular DiseaseCompletedNCT00190580Phase 4
- A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)CompletedNCT00189501
- Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.CompletedNCT00184769Phase 4
- Growth Hormone Treatment in Adult Patients With Chronic Kidney DiseaseCompletedNCT00184652Phase 2
- Active Vitamin D Effect on Left Ventricular HypertrophyTerminatedNCT00175149Phase 4
- Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney DiseaseWithdrawnNCT00169923Phase 2/3
- Hemofiltration for Contrast-Induced NephropathyStatus unknownNCT00158080Not applicable
- Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)TerminatedNCT00156962Phase 3
- EPO Deep Tank in Dialysis SubjectsCompletedNCT00156949Phase 3
- Efficacy of Pentoxifylline on Chronic Kidney DiseaseCompletedNCT00155246Phase 4
- Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected PatientsCompletedNCT00153621
- Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving HemodialysisCompletedNCT00146224Phase 3
- CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney DiseaseWithdrawnNCT00142636
- Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by InternistsWithdrawnNCT00134797
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary HyperparathyroidismCompletedNCT00132431Phase 4